Clinical Trial Search

Primary: Efficacy of Mannitol Administration in Reducing the Frequency of Intra-dialytic Hypotension (Decline in Systolic Blood Pressure) During the First Three Hemodialysis…

Primary: Teamwork Event Rate — 9; 10.3; 12.8 teamwork events per minute

Primary: Percentage of Participants With HIV-1 RNA < 50 Copies/mL at Week 48 as Defined by the US FDA-defined Snapshot Algorithm — 90.0; 92.0 percentage of participants — p=0.35

Primary: Number of Participants With Improved, Stable, or Worsened Change In Chromogranin A (CgA) Biomarker Levels From Baseline — 1; 11; 6 Participants

Primary: Percentage of Participants With an Objective Response — 39.0; 41.7 percentage of participants

Primary: Mean Change on Merz Hand Grading Scale (MHGS), by Hand — 2.6; 2.6; 1.5; 2.6 units on a scale — p=<0.0001

Primary: Change From Baseline in the Composite Score of Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB)…

Primary: Best Overall Response Rate as Determined by International Working Group Criteria — 28.6 percentage of patients with CR, PR or CI

Primary: The Primary Efficacy Endpoint is the Total Number of PRN Bevacizumab Intravitreal Injections Through 24 Weeks — 5; 19; 13; 11 Participants — p=0.00002

Primary: Treatment Efficacy — 10; 51; 0 Participants

Primary: Primary Study Endpoint — 26; 2 Participants

Primary: Percentage of Participants With Sustained Virologic Response 12 Weeks Post-treatment (SVR12) — 89.5 percentage of participants

Primary: Number of Subjects With a Vaccine Response for Serum Bactericidal Assay Using Rabbit Complement Against Neisseria Meningitides Serogroups A, C, W-135 and Y (rSBA-MenA…

Primary: Postoperative Complications — 42; 45; 24; 24 Participants

Primary: Improvement of Sleep Associated With the Use of Pseudoephedrine as Compared to the Placebo